Broadfin Capital as of June 30, 2017
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 49 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 9.4 | $77M | 1.0M | 77.18 | |
| Heron Therapeutics (HRTX) | 7.9 | $65M | 4.7M | 13.85 | |
| Horizon Pharma | 7.3 | $60M | 5.1M | 11.87 | |
| Retrophin | 6.7 | $56M | 2.9M | 19.39 | |
| Flamel Technologies Sa (AVDL) | 5.5 | $46M | 4.1M | 11.03 | |
| La Jolla Pharmaceuticl Com Par | 5.1 | $42M | 1.4M | 29.77 | |
| Aratana Therapeutics | 4.5 | $38M | 5.2M | 7.23 | |
| Endo International (ENDPQ) | 4.4 | $36M | 3.2M | 11.17 | |
| Corium Intl | 4.0 | $33M | 4.4M | 7.46 | |
| Ignyta | 3.7 | $30M | 2.9M | 10.35 | |
| AngioDynamics (ANGO) | 3.3 | $27M | 1.7M | 16.21 | |
| Recro Pharma (SCTL) | 2.6 | $22M | 3.1M | 7.03 | |
| Strongbridge Bioph shs usd | 2.5 | $21M | 2.9M | 7.15 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.5 | $20M | 7.4M | 2.76 | |
| Noveliontherapeuti.. | 2.2 | $18M | 1.9M | 9.23 | |
| Iovance Biotherapeutics (IOVA) | 2.0 | $17M | 2.3M | 7.35 | |
| Aerie Pharmaceuticals | 2.0 | $16M | 310k | 52.55 | |
| Antares Pharma | 1.9 | $16M | 4.8M | 3.22 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $15M | 181k | 79.76 | |
| BioDelivery Sciences International | 1.7 | $14M | 5.1M | 2.80 | |
| Teligent | 1.6 | $13M | 1.5M | 9.15 | |
| Gilead Sciences (GILD) | 1.6 | $13M | 180k | 70.78 | |
| Veracyte (VCYT) | 1.5 | $12M | 1.4M | 8.33 | |
| Novadaq Technologies | 1.4 | $12M | 1.0M | 11.72 | |
| Amarin Corporation (AMRN) | 1.2 | $10M | 2.5M | 4.03 | |
| Mirati Therapeutics | 1.1 | $9.1M | 2.5M | 3.65 | |
| Juno Therapeutics | 0.9 | $7.8M | 262k | 29.89 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.9 | $7.5M | 1.1M | 6.69 | |
| Progenics Pharmaceuticals | 0.8 | $6.8M | 1.0M | 6.79 | |
| Idera Pharmaceuticals | 0.8 | $6.6M | 3.9M | 1.72 | |
| Paratek Pharmaceuticals | 0.8 | $6.7M | 277k | 24.10 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.7 | $6.1M | 816k | 7.50 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.6 | $5.0M | 10M | 0.50 | |
| NuVasive | 0.5 | $4.3M | 56k | 76.92 | |
| Natus Medical | 0.5 | $4.2M | 112k | 37.30 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.5 | $4.1M | 15M | 0.27 | |
| Endologix | 0.5 | $3.8M | 779k | 4.86 | |
| Zogenix | 0.5 | $3.8M | 263k | 14.50 | |
| Aralez Pharmaceuticals | 0.3 | $2.7M | 2.0M | 1.35 | |
| Adma Biologics (ADMA) | 0.3 | $2.5M | 681k | 3.70 | |
| Glycomimetics (GLYC) | 0.3 | $2.5M | 222k | 11.16 | |
| Globus Med Inc cl a (GMED) | 0.3 | $2.2M | 67k | 33.15 | |
| Irhythm Technologies (IRTC) | 0.3 | $2.2M | 53k | 42.49 | |
| Contrafect | 0.2 | $1.9M | 1.3M | 1.45 | |
| Cogentix Medical | 0.2 | $1.9M | 1.1M | 1.74 | |
| Mediwound Ltd cmn | 0.1 | $1.2M | 175k | 6.80 | |
| Alphatec Holdings (ATEC) | 0.1 | $1.1M | 595k | 1.85 | |
| Ovascience | 0.1 | $429k | 275k | 1.56 | |
| Dextera Surgical | 0.0 | $296k | 988k | 0.30 |
